ArticlebioRxiv : the preprint server for biology2026
SGEF coordinates epithelial morphogenesis by regulating junction stability, collective migration, and extracellular matrix remodeling.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Polarized epithelia are essential for organ function, and disruption of epithelial polarity is a hallmark of many diseases, including cancer. We previously showed that the RhoG-specific guanine nucleotide exchange factor SGEF interacts with the Scribble polarity complex to regulate epithelial junction assembly in 2D monolayers. However, its role in epithelial morphogenesis and lumen formation in 3D remains unknown. Here, we combined quantitative morphometric analysis with long-term live-cell imaging to investigate the role of SGEF during MDCK cyst development. SGEF KD disrupted normal lumenogenesis, producing enlarged cysts with multiple collapsed lumens accompanied by reduced E-cadherin, β-catenin, and ZO-1 expression. Loss of SGEF also altered the distribution of the actomyosin network. Re-expression of WT SGEF restored the normal phenotype, whereas restoration of E-cadherin and ZO-1 partially rescued lumen architecture, identifying the loss of junction integrity as a key driver of the morphogenetic defects. Unexpectedly, live-cell imaging revealed increased motility and frequent cyst fusion in SGEF-KD cysts. Restoring E-cadherin levels abolished cyst migration, while inhibition of matrix metalloproteinases markedly restored normal cyst volume and lumen architecture, identifying extracellular matrix remodeling as an additional contributor to the SGEF-deficient phenotype. Together, these findings identify SGEF as a key regulator of epithelial morphogenesis, coordinating junction integrity, actomyosin organization, lumen formation, and collective migration.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.